BIODESIX INC 10-Q filing
Filed 2026-05-04 · Report date 2026-03-31 · 2026
Filing metadata
- Accession number
- 0001193125-26-203960
- Form type
- 10-Q
- CIK
- 0001439725
- Primary document
- https://www.sec.gov/Archives/edgar/data/1439725/000119312526203960/bdsx-20260331.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for BIODESIX INC.
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $25.6M | - | - |
| Operating Income | $-6.2M | - | - |
| Net Income | $-7.8M | - | - |
| Eps Basic | -0.81 | - | - |
| Eps Diluted | -0.81 | - | - |
| Cash And Equivalents | $25.6M | - | - |
| Total Assets | $94.6M | - | - |
| Total Liabilities | $85.5M | - | - |
| Shareholders Equity | $9.1M | - | - |
| Operating Cash Flow | $-10.2M | - | - |
| Capital Expenditures | $81,000 | - | - |